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Abstract (250 words) 
Introduction: Colorectal cancer is the fourth most common cancer in the United Kingdom; 
however, figures show that the uptake for bowel cancer screening lags behind other cancer 
screening programmes. Methods: This is a report of a multi-staged development of an 
outreach colorectal clinical community service provided through a Mobile Unit (a Bowel 
Bus). The unit delivers a one-stop colorectal clinic that provides a rapid access pathway to 
members of the public who have concerns about, or symptoms of, bowel cancer. The aims of 
the project were to increase public awareness about colorectal cancer and to provide an 
outreach clinic as a supplement to the hospital based colorectal clinic. This service is a result 
of collaborative efforts between Tenovus Cancer Care (TCC) and the colorectal surgery 
department of the local NHS Hospital. Results: During one year, the Bowel Bus has provided 
services to 772 members of the local community. 244 patients were examined by the 
colorectal nurse specialist including 66 drop-in patients and 135 patients referred by the GPs. 
The service led to decrease in the waiting list for routine referrals to be seen in the colorectal 
clinic at the hospital from a mean of 10.5 weeks to 5.9 weeks. A feedback questionnaire from 
180 patients, used to audit the quality of the service, has confirmed an overwhelming 
satisfaction with the service. Conclusion: The Mobile Unit is a novel solution to addressing 
the ever increasing demand for specialist outpatient services without compromising the 
quality of care whilst enhancing the patient experience.  
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Introduction 
Colorectal cancer is the fourth most common cancer in the United Kingdom with 41,500 new 
patients diagnosed annually, equivalent to a new patient diagnosed every 15 minutes. It is the 
second common cause of cancer mortality with about 16,000 patients dying per annum. The 
5-year survival rate for patients diagnosed at early stage exceeds 97%1. Unfortunately, only 
less than 13% of cases are diagnosed early and public participation in the screening programs 
remains poor worldwide, but also in the United Kingdom, particularly in Wales2.  
Many different studies have shown that the public awareness of the signs of cancer is 
generally poor3, 4 notwithstanding the social taboos around discussing the symptoms5. Bowel 
cancer screening programmes may reduce the risk of dying from bowel cancer by 16%6; 
however, figures show that the uptake for bowel cancer screening lags behind other cancer 
screening programmes including breast and cervical cancer7.  Uptake of screening in Wales 
in some areas is less than 50%. Consistent efforts are required to ensure that the appropriate 
public health messages are conveyed, to improve outcomes8.  
This paper describes a pilot project exploring the feasibility and acceptability of developing a 
Rapid Access Colorectal Clinic in a community setting. It is a partnership project between 
Tenovus Cancer Care (TCC), Wales’ largest cancer charity, with the Department of 
Colorectal Surgery at a local District General Hospital. The project is based on utilizing a 
Mobile Unit as a space in the community to deliver a colorectal clinic providing a rapid 
access pathway to members of the public who have concerns about, or symptoms of, bowel 
cancer. In addition, it also provides a ‘drop in’ service for asymptomatic members of the 
public and functions as a public health resource in raising awareness of cancer in general as 
well as bowel cancer in particular.  
 
Methods 
This is a report of a multi-staged development of an outreach colorectal clinical community 
service provided through a Mobile Unit. This service is delivered in a catchment which 
includes some of the areas with the highest health deprivation and lowest socio-economic 
status in the UK9.  TCC provides a Mobile Cancer Support Unit, which has become known 
locally as the ‘Bowel Bus’ and financial support towards a specialist colorectal nurse as well 
as some administrative costs  and publicising the project in the local press. The clinical 
service on the Mobile Unit is provided mainly by an experienced colorectal nurse specialist 
who has been trained to a high standard (Band 8A) and has been independently examining 
patients referred to the colorectal service for the past 10 years in the regular hospital 
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colorectal clinic10. The specialist nurse is supported by a consultant colorectal surgeon. In 
addition, access to psychosocial support services, such as welfare benefits advice and 
counselling, are also available on board as necessary. 
The project was developed in a staged fashion with detailed prospective data collection and 
patient satisfaction surveys.  As the Mobile Unit weighs 30 tonnes and takes up 16 car 
parking places, suitable sites were selected based on pedestrian traffic loads around the local 
town centre/ shopping area for the Bowel Bus to be located every Monday for the whole day.  
The first stage of the project started in March 2015 for 6 months providing easy access to 
members of the public to drop in. A variety of services were available including leaflets on 
colorectal conditions, advice about the national bowel cancer screening programme and the, 
opportunity to seek general advice regarding cancer. In addition, a clinical consultation 
including a general, abdominal and rectal examination (with rigid sigmoidoscopy) was also 
available. There were also volunteers from TCC who were positioned in the vicinity, to offer 
some advice to those who were not inclined to enter the Bus. See Figure 1. 
Figure 1: The bowel bus 
Based on the success of stage 1, the second stage was implemented as a pilot in September 
2015, to evaluate the feasibility and acceptability of translating this concept to a symptomatic 
group of patients rather than asymptomatic members of the public. Patients who had been 
referred to the local hospital’s Colorectal Clinic were contacted by telephone and given a 
choice of being seen either at the usual outpatient clinic or at the Bowel Bus.  It was made 
clear that if they chose the Bowel Bus, they would be seen by one of the regular clinicians 
who run the hospital colorectal clinic.  Great care was taken not to offer an earlier 
appointment or incentivize the Bus in any way. Patient referrals were triaged according to a 
set of criteria to assess if they were safe to be seen off site. Following the success of the pilot, 
the third stage was implemented from October 2015, providing a regular Rapid Access 
Colorectal Clinic in the community through the Bowel Bus, complementing the hospital 
based outpatient service. Statistical analysis was performed using Fisher’s Exact Test, 
Likert’s scale and Student’s t-test. 
 
Results 
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During the first 12 months of the service the Mobile Unit was made available in the 
community on 41 Mondays (March 2015 to February 2016), and has provided the following 
services to the local community:  
• Conversations about the signs and symptoms of bowel cancer with 772 
members of the public  
• A total of 373 visitors coming on board the Bowel Bus 
• Ten people referred to the Bowel Screening Programme  
• When indicated, these patients were referred for investigations such as  CT 
colonography, Barium enema, endoscopy, MRI, endo-anal ultrasound, blood 
tests, and faecal calprotectin etc. A total of 244 individuals examined by the 
specialist nurse of which: 
o 66 asymptomatic drop-ins 
o 135 new patients referred to rapid access colorectal service by GPs 
o 43 follow up patients from either of the above 2 groups 
o Male: Female = 93: 108, median age 55 years (range 19 to 86 years) 
o 141 endoscopic procedures were performed including 89 flexible 
sigmoidoscopy, 41 colonoscopy and 11 gastroscopy. 68 CT 
colonography  and 65 Barium enema were also performed. 
o In 148 (60.7%) patients, there was no pathology reported up on 
investigations.  
o 57 (23.4%) patients had diverticular disease, one of them had 
diverticular stricture 
o 23 (9.4%) patients had colorectal polyps and 3 patients had malignant 
tumours; in the caecum, lower rectum and lung. 
 
The waiting time for routine referrals to the colorectal unit in the DGH has dropped from a 
mean of 10.5 weeks at the beginning of the symptomatic patient service at the Mobile Unit to 
5.9 weeks after six months, p < 0.0001. 
The data from the Health Board information services show that the rate of patients who do 
not attend (DNA) in the outpatients clinics is significantly lower in the mobile (6.6%) unit 
when compared to the hospital out-patients clinics (11.4%), p= 0.035. 
Questionnaires to evaluate the experience were completed by 180 individuals who received 
examination (patients/ asymptomatic drop-ins), since September 2015. The results showed a 
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very positive feedback as reflected by the high average scores on the 5-points Likert’s scale 
(Mean = 4.8, 4.6, 4.7 and 4.7 for questions 1-4, respectively).  98% of the respondents rated 
the concept of the Bowel Bus as Good/ Very Good and confirmed that they would be willing 
to use the facility themselves again (92%) and would recommend to a friend (96%). Most 
users found the facility to be attractive due to ease of access, car parking and the majority 
found the experience preferable to attending a clinic at the hospital. Detailed results are 
summarised in Figure 2.  
Figure 2: User Experience Questionnaire 
Discussion 
In 2006 the NHS Bowel Cancer Screening Programme for England was introduced, 
following the evaluation of a pilot screening programme, which had begun in 200011. 
Screening using faecal occult blood test, followed by colonoscopic assessment for patients 
testing positive was implemented and has been predicted to reduce bowel cancer mortality by 
up to 16%6. 
Unfortunately, the uptake for bowel cancer screening program remains low in the United 
Kingdom being 58% and 52.6% in England and Wales, respectively. These figures lag behind 
those for breast cancer screening (72%) and cervical cancer screening (79%)7. There is also a 
24% difference between the lowest and highest areas of uptake across England and Wales 
(42-66%)12. The uptake in the local community served by this project was 54%.  The reasons 
for the low uptake remain unclear in the literature with the available evidence suggesting a 
number of approaches to potentially increase the bowel cancer awareness among the general 
public and improve the uptake for the bowel screening programme. These include GP 
endorsement letters, enhanced patients leaflets, telephone advice, face to face health 
promotion and advertising13, 14.  Replacing the Haemoccult® test requiring 3 samples with the 
new Faecal Immunochemical Test which requires one stool sample using a simple and 
cleaner sampling technique with an easy-return postal package has been demonstrated to 
result in an increase in participation rates in a large pilot study15.  
Over the past 20 years, both the number of patients and the complexity of cases requiring 
treatment in the community have increased16. Demographic changes, technological advances, 
the changing pattern of disease as well as of patient expectations have driven this growth. At 
the same time, there has been no commensurate shift of resources and expertise to the 
community. Consultants have become increasingly specialised in their knowledge and have 
continued to remain predominantly based in the secondary care sector. This has left many 
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patients struggling to get appropriate care in the community with ever increasing waiting 
times for hospital appointments with potential delays in diagnosis and/or treatment17. The 
report in 2013 by the Future Hospital Commission to the Royal College of Physicians called 
for radical changes to the way hospitals are structured with   multi-professional clinical teams 
bridging hospital and community settings to provide a co-ordinated service, closer to 
patients’ homes. This approach is very different to the traditional model for shifting specialist 
care to the community, which predominantly consisted of consultant-run outreach clinics 
based in a community hospital or GP practice18, 19.  
The concept of Mobile Units providing clinical services is not new20.  These models of 
healthcare delivery have been used for decades in the developing world to compensate for 
lack of infrastructure in rural areas.  More recently, reports from mobile cancer screening 
coaches were launched in 2013 by Cancer Care Ontario in Canada providing screening for 
breast, cervical and colorectal cancers.21.  There are also recent examples in the United 
Kingdom with promising and satisfactory results22. The Bowel Bus project reported here has 
demonstrated that it is possible to achieve these objectives even for conditions with socially 
embarrassing symptoms by utilising the expertise of a highly trained colorectal nurse 
specialist even in areas with significant deprivation. We are currently exploring the 
possibility of extending this service to include immediate flexible sigmoidoscopy for suitable 
patients, to bring the mobile outreach service in line with our hospital-based one stop 
colorectal clinic.  
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